World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
28681
World Ranking
14082
National Ranking
7145

Overview

Susan L. Cohn is affiliated with the University of Chicago in the United States. Their research career focuses extensively on medicine, with significant contributions in biochemistry, genetics, and molecular biology. Within these broader fields, their work is particularly concentrated in subfields such as neurology, cancer research, pediatrics, perinatology and child health, molecular biology, and oncology.

Their research primarily addresses topics including neuroblastoma research and treatments, cancer, hypoxia, and metabolism, cancer therapeutics and mechanisms, the quality of life of childhood cancer survivors, neurofibromatosis and schwannoma cases, glioma diagnosis and treatment, as well as lung cancer research studies.

Susan L. Cohn has published numerous papers in several prominent scientific venues. Frequent publication venues of their work include:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • JCO Clinical Cancer Informatics
  • Clinical Cancer Research
  • Cancer

Their recent papers highlight research on neuroblastoma and related therapies. Notable publications include:

  • "Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group" (2021, Journal of Clinical Oncology)
  • "Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032" (2021, Clinical Cancer Research)
  • "Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium" (2021, Journal of Clinical Oncology)
  • "Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project" (2020, Journal of Clinical Oncology)
  • "Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future" (2020, JCO Clinical Cancer Informatics)

Frequent collaborators include several researchers with whom Susan L. Cohn has coauthored multiple publications. These coauthors are:

  • Arlene Naranjo
  • Wendy B. London
  • Julie R. Park
  • Mark A. Applebaum
  • Ami V. Desai

Best Publications

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.

    Dafna Meitar;Susan E. Crawford;Alfred W. Rademaker;Susan L. Cohn

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma

    Murray D. Norris;Sharon B. Bordow;Glenn M. Marshall;Paul S. Haber

  • Children's Oncology Group's 2013 blueprint for research: Neuroblastoma

    Julie R. Park;Rochelle Bagatell;Wendy B. London;John M. Maris

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

    Suzanne S. Shusterman;Wendy B. London;Stephen D. Gillies;Jacquelyn A. Hank

  • Advances in the diagnosis and treatment of neuroblastoma

    Joanna L. Weinstein;Howard M. Katzenstein;Susan L. Cohn

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

  • Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

    Susan G Kreissman;Robert C Seeger;Katherine K Matthay;Wendy B London;Wendy B London

  • Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.

    Julie R. Park;Julie R. Park;Susan G. Kreissman;Wendy B. London;Arlene Naranjo

  • Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

    Meredith S Irwin;Arlene Naranjo;Fan F Zhang;Susan L Cohn

  • Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

    Birgit Geoerger;Hyoung Jin Kang;Michal Yalon-Oren;Lynley V Marshall

  • Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

    Julie R Park;Rochelle Bagatell;Susan L Cohn;Andrew D Pearson

Frequent Co-Authors

Wendy B. London
Wendy B. London Harvard University
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Garrett M. Brodeur
Garrett M. Brodeur Children's Hospital of Philadelphia
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
A. Thomas Look
A. Thomas Look Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn't limited to becoming a doctor. There are numerous online degrees and pathways offering flexibility and affordability for aspiring healthcare professionals. For registered nurses seeking to advance their qualifications, consider enrolling in the cheapest rn to bsn program online to complete your Bachelor of Science in Nursing at a reduced cost.

Those with a non-nursing background but interested in nursing can look into direct entry msn programs for non-nursing majors online. These programs enable career changers to enter the nursing field with an accelerated master’s degree.

Applicants who are concerned about competitive admissions may benefit from reviewing nursing programs with high acceptance rates, which provide more accessible entry points to starting a nursing career.

Beyond direct patient care, prospective students can also enter the healthcare industry through administrative roles. Accredited online options, like accredited medical billing and coding schools online with financial aid, offer an affordable way to qualify for essential positions in medical records and billing.

Best Scientists Citing Susan L. Cohn

Trending Scientists

Recently Published Articles